Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2011 by Li Li, Next Capital (嘉程资本) is an early-stage investment firm based in China. The firm specializes in angel investments and currently manages a portfolio of 15 companies. It focuses on technology-driven investments across various sectors, including consumer goods, healthcare, and fintech.
Next Capital invests in early-stage companies during the angel round, particularly those that disrupt existing markets or create new value chains. The firm targets sectors such as AI, robotics, biotech, and web3, with check sizes typically aligned with early-stage funding needs. Their commitment includes building a supportive community for entrepreneurs through various service offerings.
Next Capital's notable investments include 元气森林 (Genki Forest), a health-focused beverage company; 硅基仿生 (Silicon Bionic), which develops blood glucose monitoring devices; and 熊猫速汇 (Panda Remit), a fintech platform for global remittances. Other portfolio companies include 士泽生物 (Shizai Biotechnology), 荷声科技 (HeSheng Technology), and 多抓鱼 (Duozhuayu).
Email your pitch deck to bp@jiachengcap.com for consideration.
Next Capital typically participates in angel rounds, often leading investments in early-stage companies that align with their focus on technology-driven innovation.
The firm is open to follow-on investments, particularly for companies that demonstrate strong growth potential and align with their investment thesis.
Specific fund size details are not disclosed, but Next Capital actively manages a portfolio of 15 companies across various sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.